Company: BLTE
Filing Date: 2025-10-22
Form Type: F-3ASR
Source: 0001104659-25-101403
Chunk: 77

Company: BELITE BIO, INC
Filing Date: 2025-10-22
Form: F-3ASR
Chunk 77
---
 execute any and all instruments which said attorney and agent may deem necessary or desirable to enable the registrant to comply with the Securities Act of 1933, as amended (the “Securities Act”), and any rules, regulations and requirements of the Securities and Exchange Commission thereunder, in connection with this Registration Statement, including, without limitation, the power and authority to sign the name of each of the undersigned in the capacities indicated below to this Registration Statement to be filed with the Securities and Exchange Commission, to any and all amendments or supplements to such Registration Statement, whether such amendments or supplements are filed before or after the effective date of such Registration Statement, and to any and all instruments or documents filed as part of or in connection with such Registration Statement or any and all amendments thereto, whether such amendments are filed before or after the effective date of such Registration Statement; and each of the undersigned hereby ratifies and confirms all that such attorney and agent shall do or cause to be done by virtue hereof. Pursuant to the requirements of the Securities Act, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated:

| ​ 
 ​ 
 ​ | Signature and Name  
 /s/ Yu-Hsin Lin     
 ​                   
 Yu-Hsin Lin         
 /s/ Wan-Shan Chen   
 ​                   
 Wan-Shan Chen       | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | Title                                                                                     
 Chief Executive Officer, Chairman of the Board of Directors (Principal Executive Officer) 
 Director                                                                                  | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | Date             
 October 22, 2025 
 October 22, 2025 | ​ 
 ​ 
 ​ |
|:--|:--------------------|:--|:--|:------------------------------------------------------------------------------------------|:--|:--|:-----------------|:--|
| ​ | /s/ Xiao-Hui Chen   
 ​                   
 Xiao-Hui Chen       | ​ | ​ | Director                                                                                  | ​ | ​ | October 22, 2025 | ​ |
| ​ | /s/ Hao-Yuan Chuang 
 ​                   
 Hao-Yuan Chuang     | ​ | ​ | Chief Financial Officer, Director (Principal Financial and Accounting Officer)            | ​ | ​ | October 22, 2025 | ​ |
| ​ | /s/ John M. Longo   
 ​                   
 John M. Longo       | ​ | ​ | Director                                                                                  | ​ | ​ | October 22, 2025 | ​ |
| ​